ArticleBMJ nutrition, prevention & health2025
Association of serum vitamin D levels and dietary vitamin D intake with latent tuberculosis infection and long-term mortality: a population-based cohort study.
Article in BMJ nutrition, prevention & health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vitamin D plays a crucial role in immune function and respiratory infections, yet its association with latent tuberculosis infection (LTBI) and long-term mortality remains unclear. This study investigates the relationship between serum 25-hydroxyvitamin D levels, dietary vitamin D intake, LTBI risk and mortality. Method: We analysed data from the 2011-2012 cycle of the US National Health and Nutrition Examination Survey, including 5286 adults (≥18 years) who underwent tuberculosis (TB) testing. Serum 25-hydroxyvitamin D levels were measured using high-performance liquid chromatography-tandem mass spectrometry, and dietary vitamin D intake was assessed via a 24-hour dietary recall. LTBI was defined as an induration>10 mm on the Tuberculin Skin Test or a positive QuantiFERON-TB Gold-In-Tube test. Mortality data were obtained through linkage with the National Death Index, with follow-up until 31 December 2019. Results: Among 5286 participants, 708 (13.4%) had LTBI. Individuals with LTBI had significantly lower serum 25-hydroxyvitamin D levels than those without LTBI. A 10 nmol/L increase in serum 25-hydroxyvitamin D was associated with a 5% lower risk of LTBI (adjusted OR: 0.95, 95% CI: 0.92 to 0.99, p<0.05). Among LTBI participants, low serum 25-hydroxyvitamin D levels (<50 nmol/L) were independently associated with a higher risk of all-cause mortality (adjusted HR: 3.45, 95% CI: 1.33 to 8.90, p<0.05). However, dietary vitamin D intake was not significantly associated with LTBI risk or long-term mortality. Conclusion: Vitamin D deficiency was associated with an increased risk of LTBI and long-term mortality in this population-based study. Although adequate serum 25-hydroxyvitamin D levels were linked to more favourable outcomes, the role of vitamin D supplementation in individuals with TB infection remains uncertain. Further research is needed to clarify these associations and guide evidence-based supplementation strategies for TB prevention and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.